Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction
Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction

Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction

Demms Dezzy

2 min
Knowledge
Play

Description

<p> Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction https://doi.org/10.1016/j.hlc.2023.03.010 Abstract Background: The pleiotropic action of <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/ticagrelor">ticagrelor</a>, with effects in addition to platelet inhibition, has been shown to improve <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/endothelial-function">endothelial function</a> in patients with <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/coronary-artery-disease">coronary artery disease</a>. These positive effects are possibly adenosine mediated. This study investigated the association of ticagrelor therapy and coronary artery flow reserve in survivors of myocardial infarction (MI).   Methods: This was an exploratory, cross-sectional, open substudy of PROFLOW. High-risk individuals with a history of MI were identified. <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/coronary-flow-reserve">Coronary flow reserve</a> (CFR) was measured non-invasively in the left anterior descending artery using transthoracic <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/doppler-echocardiography">Doppler echocardiography</a>. Coronary flow velocity was measured at rest and at maximal flow after induction of <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/hyperaemia">hyperaemia</a> by <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/intravenous-drug-administration">intravenous infusion</a> of adenosine at 140 μg/kg/min. Patients receiving ticagrelor (n=75) were compared with those not receiving ticagrelor (n=506), using simple and <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/multiple-linear-regression-analysis">multiple linear regression</a> models. Most patients in both groups were treated with <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/acetylsalicylic-acid">aspi

Uploader

tommyBee

tommyBee

Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction - Listen Free | WowFM